GlycoNex Incorporation Total Current Liabilities

GlycoNex Incorporation (4168.TWO) currently reports a total current liabilities of $57M as of June 2026. That compares with $280M in the prior-year period — down 79.2% year over year. Use the charts on this page to explore GlycoNex Incorporation's total current liabilities history and peer comparisons.

GlycoNex Incorporation's total current liabilities decreased from $280M to $57M — a 79.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GlycoNex Incorporation reported $57M in total current liabilities as of June 2026. That compares with $280M in the prior-year period — down 79.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $57M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GlycoNex Incorporation, and consider following 4168.TWO for alerts when major investors trade the stock.

GlycoNex Incorporation is classified in the Healthcare sector. On total current liabilities, it currently shows $57M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4168.TWO with unrelated industries.